Azhar M Nomair

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Silver Nanoparticles

Rheumatoid Arthritis Patients

Top Venues

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Azhar M Nomair, Abeer Ali Abdelati, Fatma I Dwedar, Rehab Elnemr, Yasmine N Kamel, Hanan Mohamed Nomeir
The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients. Clinical rheumatology 43 (3) (2024)
Azhar M Nomair, Abeer Ali Abdelati, Fatma I Dwedar, Rehab Elnemr, Yasmine N Kamel, Hanan Mohamed Nomeir
The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients. Clinical rheumatology 43 (3) (2024)
Azhar M Nomair, Abeer Ali Abdelati, Fatma I Dwedar, Rehab Elnemr, Yasmine N Kamel, Hanan Mohamed Nomeir
The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients. Clinical rheumatology 43 (3) (2024)
Azhar M Nomair, Abeer Ali Abdelati, Fatma I Dwedar, Rehab Elnemr, Yasmine N Kamel, Hanan Mohamed Nomeir
The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients. Clinical rheumatology (2024)
Azhar M Nomair, Abeer Ali Abdelati, Fatma I Dwedar, Rehab Elnemr, Yasmine N Kamel, Hanan Mohamed Nomeir
The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients. Clinical rheumatology 43 (3) (2024)
Azhar M Nomair, Abeer Ali Abdelati, Fatma I Dwedar, Rehab Elnemr, Yasmine N Kamel, Hanan Mohamed Nomeir
The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients. Clinical rheumatology 43 (3) (2024)